罗马假日

“聚力同行乐透出彩”2026年青浦区体彩销售人员趣味运动会圆满举行_我的网站

源代码

一 | 8月7日下午，以“聚力同行乐透出彩”为主题的2026年青浦区体彩销售人员趣味运动会在万达茂A座中庭火热开赛。本次活动也是2026年青浦区全民健身日主题活动的重要组成部分，来自全区各体育彩票销售网点的约100名销售人员齐聚一堂，在欢声笑语中展现公益体彩人的活力与风采。 (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。
　　本次活动由青浦区体育局主办，旨在丰富体彩销售人员的业余文化生活，缓解长期驻店的工作压力，增强行业归属感与团队凝聚力，同时向社会传递公益体彩健康向上的积极形象。

二 | 活动现场气氛热烈，参赛人员以随机组队形式分为多支8人队伍，通过团队协作完成五项兼具趣味性与竞技性的体彩主题团体项目。
　　比赛中，“幸运飞镖数字靶”考验精准与运气，全队轮流上阵、争分夺秒；“接招大挑战”需要默契配合，有效回击方显实力；“蒙眼数字投球大挑战”则凭借队友的精准口头指挥，在蒙眼旋转后完成投球任务，充分体现了信任与沟通；“同心拉力圈运彩球”以三人的细微操控将彩球平稳运送至指定点位，展现了极致的团队协作；而“全队协力有氧鼓”项目则通过限时磨合与整齐划一的鼓点节奏，将全队士气与团队配合度推向高潮。各参赛队伍全情投入、文明竞技，赛场上加油声、欢呼声此起彼伏，充分展现了体彩人拼搏进取、团结向上的精神风貌。
　　经过激烈而欢乐的比拼，最终决出团体一等奖1名、二等奖2名、三等奖3名。主办方为获奖队伍颁发了奖状及定制奖品，并为所有参赛队伍准备了活动纪念礼品，以此感谢广大体彩销售人员长期以来的辛勤付出与积极贡献。
　　本次趣味运动会的成功举办，不仅为体彩销售人员搭建了放松身心、增进交流的平台，也进一步增强了行业凝聚力与荣誉感。